Featured

Brilinta® vs. Plavix® in Patients with Acute Coronary Syndromes

By: Ronik Saha, Pharm.D. Candidate c/o 2013 - Clopidogrel (Plavix®) is a thienopyridine antiplatelet agent, which exerts its antiplatelet effects…

14 years ago

Proton Pump Inhibitors and the Treatment of Osteoporosis

By: Neal Shah - Osteoporosis is a disease of the bone characterized by decreased bone mineral density (BMD), which reduces…

14 years ago

Pharmacists Are Healthcare Providers!

By: Sandra Leal Pharm.D., CDE -  Sandra Leal, PharmD, CDE is the Director of Clinical Pharmacy at El Rio Health…

14 years ago

Adapting to the Changing Roles in Pharmacy

By: Kate Croegaert, University of Iowa College of Pharmacy, Pharm.D. Candidate c/o 2013 - Kate Croegaert is a PharmD Candidate (Class…

14 years ago

Bydureon®: A Weekly Injection for Type 2 Diabetes Mellitus

By: Mohamed Dungersi - On January 27, the FDA approved Bydureon® (exenatide extended-release) for use in Type 2 Diabetes Mellitus…

14 years ago

A Message from the New Rho Chi President

By: Yining Shao - Greetings fellow Rho Chi members and fellow pharmacy candidates! In thinking about my presidency, the following…

14 years ago

Hope on the Horizon: Chikungunya Vaccine Trial Begins!

By: Ebey P. Soman - Since its discovery in Tanganyika (modern day Mozambique and Tanzania in Africa) in 1952, Chikungunya…

14 years ago

New Oral Direct Thrombin Inhibitors and Factor Xa Anticoagulants

By: Neal Shah - Anticlotting agents are staples in the prevention and treatment of thrombotic disorders, such as deep vein…

14 years ago

FDA Challenges Pharmacists’ Right to Compound

By: Ebey P. Soman - With clearly established roles for pharmacists, compounding is recognized and upheld as a core foundation…

14 years ago

Clevidipine in the Management of Hypertensive Emergency

By: Neal Shah - Defined by the Joint National Committee, hypertension (HTN) is a systolic blood pressure (SBP) greater than…

14 years ago